Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

KeyGene and GENALICE Join Forces

Published: Wednesday, October 30, 2013
Last Updated: Wednesday, October 30, 2013
Bookmark and Share
KeyGene purchased a license of GENALICE MAP, a groundbreaking new sequence-mapping tool to accelerate and improve DNA research.

KeyGene is an Agro-industrial Biotech company focusing on genomic research and technology development to accelerate crop improvement. Using cutting-edge molecular genetic technologies, such as next-generation sequencing, KeyGene has a leading and innovative role in this market. “The breakthrough software solution, GENALICE MAP, is a leap forward in improving our analysis pipeline and in staying ahead of competition. We tested, validated and now implemented MAP, as it immediately offers us major competitive advantages on speed and accuracy in DNA analysis. In addition, the strategic partnership with GENALICE allows us to influence new functionalities within the product that will benefit our business,” comments Arjen van Tunen, CEO of KeyGene”.

GENALICE is a young and innovative Dutch software company. In a worldwide online launching event it will present its first product to all DNA researchers in the world on 12/12 later this year. “This first commercial deal, even before the official launch of our product, shows the quality of our product and the need for GENALICE MAP in the field of DNA data processing.” says Hans Karten, CTO of GENALICE.

Jos Lunenberg, CEO of GENALICE, further comments: “We are extremely pleased with the partnership with KeyGene. It clearly shows that GENALICE MAP is highly welcomed in the field of plant genomics. Plant DNA is often far more complex than human DNA. This demonstrates that we are also well positioned to deal with complex variations in DNA, which is found in complex diseases such as cancer. On top of this, our product is up to 200 times faster than most commonly used tools and it reduces the data footprint significantly. This makes MAP, apart from the most accurate and fastest, also the most cost-effective solution in this market”.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

GENALICE Prepares For Software Launch with Management Realignment
Company to launch raw DNA sequence data processing software.
Thursday, April 18, 2013
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
Investigating the Vape
Expert independent review concludes that e-cigarettes have potential to help smokers quit.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Researchers Discover Synthesis of a New Nanomaterial
Interdisciplinary team creates biocomposite for first time using physiological conditions.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
Marijuana Genome Unraveled
A study by Canadian researchers is providing a clearer picture of the evolutionary history and genetic organization of cannabis, a step that could have agricultural, medical and legal implications for this valuable crop.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!